Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 3
2000 4
2001 2
2003 6
2004 5
2005 5
2006 11
2007 16
2008 21
2009 9
2010 11
2011 8
2012 10
2013 12
2014 10
2015 7
2016 2
2017 5
2018 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Tadalafil therapy for pulmonary arterial hypertension.
Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, Shapiro S, White RJ, Chan M, Beardsworth A, Frumkin L, Barst RJ; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group. Galiè N, et al. Circulation. 2009 Jun 9;119(22):2894-903. doi: 10.1161/CIRCULATIONAHA.108.839274. Epub 2009 May 26. Circulation. 2009. PMID: 19470885 Clinical Trial.
Riociguat for the treatment of pulmonary arterial hypertension.
Ghofrani HA, Galiè N, Grimminger F, Grünig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ; PATENT-1 Study Group. Ghofrani HA, et al. N Engl J Med. 2013 Jul 25;369(4):330-40. doi: 10.1056/NEJMoa1209655. N Engl J Med. 2013. PMID: 23883378 Free article. Clinical Trial.
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators. Galiè N, et al. N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687. N Engl J Med. 2015. PMID: 26308684 Free article. Clinical Trial.
Bosentan in systemic sclerosis.
Heresi GA, Minai OA. Heresi GA, et al. Among authors: minai oa. Drugs Today (Barc). 2008 Jun;44(6):415-28. doi: 10.1358/dot.2008.44.6.1220138. Drugs Today (Barc). 2008. PMID: 18596996 Review.
Natural history of emphysema.
Minai OA, Benditt J, Martinez FJ. Minai OA, et al. Proc Am Thorac Soc. 2008 May 1;5(4):468-74. doi: 10.1513/pats.200802-018ET. Proc Am Thorac Soc. 2008. PMID: 18453357 Free PMC article. Review.
Comorbidities in chronic obstructive pulmonary disease.
Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Chatila WM, et al. Among authors: minai oa. Proc Am Thorac Soc. 2008 May 1;5(4):549-55. doi: 10.1513/pats.200709-148ET. Proc Am Thorac Soc. 2008. PMID: 18453370 Free PMC article. Review.
Manifestations of scleroderma pulmonary disease.
Minai OA, Dweik RA, Arroliga AC. Minai OA, et al. Clin Chest Med. 1998 Dec;19(4):713-31, viii-ix. doi: 10.1016/s0272-5231(05)70112-x. Clin Chest Med. 1998. PMID: 9917962 Review.
Cardiac disease in chronic obstructive pulmonary disease.
Falk JA, Kadiev S, Criner GJ, Scharf SM, Minai OA, Diaz P. Falk JA, et al. Among authors: minai oa. Proc Am Thorac Soc. 2008 May 1;5(4):543-8. doi: 10.1513/pats.200708-142ET. Proc Am Thorac Soc. 2008. PMID: 18453369 Free PMC article. Review.
136 results